Lp(a) for Professionals
Lp(a) is a genetic independent risk factor for cardiovascular disease.
An estimated 20% to 30% of people worldwide have high levels of plasma lipoprotein(a).
It is important for clinicians to incorporate comprehensive guidelines for diagnosing, treating, and managing elevated Lp(a) into patient evaluation and risk assessment.
Toolkits
Lp(a): A Toolkit for Healthcare Professionals
Elevated Lp(a) is associated with heightened risk for myocardial infarction, peripheral artery disease, stroke, and calcific aortic valve disease. Learn more in this toolkit for healthcare professionals.
Videos On Demand
Address gaps in your knowledge about Lipoprotein(a) and LDL-C. Watch these evidence-based on demand videos to learn the latest science and gain expert insights into incorporating the measurement of Lp(a) into patient evaluation and risk assessment. CE and MOC available.
Lp(a) in Clinical Practice:
Guidelines & Special Populations
Lipoprotein(a)
The Science Behind the Risk Factor
W.O.W.
Why hOw and When to measure Lipoprotein(a): A Clinically Relevant Cardiovascular Risk Factor
Approaches to Identification
Approaches to identification and management of patients with increased LDL-C and Lp(a)
Lp(a): An Atherosclerotic Cardiovascular Disease (ASCVD)
Risk Factor That Can No Longer Be Ignored
This webinar will provide education for health care professionals on genetics and the importance of measuring Lp(a) levels. Leading experts will address comprehensive clinical recommendations to incorporate patient-centered care for diagnosing, treating, and managing patients with elevated Lp(a).
Additional Resources
- Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association
- Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
- Lipoprotein(a) - CDC
- PAD for Professionals Page
- PAD National Action Plan
- PAD Patient Resources
Lp(a) Patient Education Resources
Talking to patients about their Lp(a) levels can help reduce their risk of heart disease. Check out these free downloadable Patient Education Resources to use in conversation with your patients:
Guidelines-on-the-Go
The Guidelines-on-the-Go App features the 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients with Hypertrophic Cardiomyopathy, plus so much more.